Peripheral Cushingoid Syndrome ('Equine Metabolic Syndrome')

Current Therapy in Equine Medicine: Fifth Edition

Volumn , Issue , 2003, Pages 812-816

  Johnson, Philip J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4444255175     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9540-2.50221-8     Document Type: Chapter

References (17)

1. Boden G Pathogenesis of type 2 diabetes: insulin resistance. Endocrinol Metab Clin North Am 2001, 30:801-815.
2. Bujalaska IJ, Kumar S, Stewart PM Does central obesity reflect "Cushing's disease of the omentum?". Lancet 1997, 349:1210-1213.
3. Cosentino F, Luscher TF Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998, 32(Suppl 3):S54-S61.
4. Freestone JF, Beadle R, Shoemaker K, et al. Improved insulin sensitivity in hyperinsulinaemic ponies through physical conditioning and controlled feed intake. Equine Vet J 1992, 24:187-190.
5. Garcia MC, Beech J Equine intravenous glucose tolerance test: glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma. Am J Vet Res 1986, 47:570-572.
6. Giugliano D, Ceriello A, Paolisso G Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
7. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
8. Montague CT, O'Rahilly S The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000, 49:883-888.
9. Poitout V, Robertson RP Minireview: secondary β-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002, 143:339-342.
10. Rask E, Olsson T, Soderberg S, et al. Tissue specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metabol 2001, 86:1418-1421.
11. Schiekofer S, Balletshofer B, Andrassy M, et al. Endothelial dysfunction in diabetes mellitus. Semin Thromb Hemost 2000, 26:503-511.
12. Shuldiner AR, Yang R, Gong D-W Resistin, obesity, and insulin resistance-the emerging role of the adipocyte as an endocrine organ. N Engl J Med 2001, 345:1345-1346.
13. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
14. Taylor AA Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinol Metab Clin North Am 2001, 30:983-997.
15. Ting HH, Timimi FK, Boles KS, et al. Vitamin C improves endothelium-dependent vasodilatation in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1996, 97:22-28.
16. Uemura S, Matsushita H, Li W, et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 2001, 88:1291-1298.
17. Watts GF, Playford DA Dyslipoproteinemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in noninsulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 1998, 41:17-30.